Details of the Drug

General Information of Drug (ID: DMDZO9Y)

Drug Name

HA20

Indication

Disease Entry	ICD 11	Status	REF
Lymphoma	2A80-2A86	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Clinical pipeline report, company report or official report of Immunomedics.